Implantable cardioverter–defibrillator therapy in congenital heart disease

References

• Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. First of two parts. N. Engl. J. Med.342(4), 256–263 (2000).
   PubMed Web of Science ®Google Scholar
• Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am. J. Cardiol.86(10), 1111–1116 (2000).
   PubMed Web of Science ®Google Scholar
• Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J. Am. Coll. Cardiol.32(1), 245–251 (1998).
   PubMed Web of Science ®Google Scholar
• Engelfriet P, Boersma E, Oechslin E et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur. Heart J.26(21), 2325–2333 (2005).
   PubMed Web of Science ®Google Scholar
• Epstein AE, Dimarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm5(6), E1–E62 (2008).
   PubMedGoogle Scholar
• Azevedo VM, Albanesi Filho FM, Santos MA et al. Is myocardial performance index an independent echocardiographic marker of death in children with idiopathic dilated cardiomyopathy?. Clin. Cardiol.31(9), 424–430 (2008).
   PubMed Web of Science ®Google Scholar
• Matias C, Isla LP, Vasconcelos M et al. Speckle-tracking-derived strain and strain-rate analysis: a technique for the evaluation of early alterations in right ventricle systolic function in patients with systemic sclerosis and normal pulmonary artery pressure. J. Cardiovasc. Med.10(2), 129–134 (2009).
   Google Scholar
• Miller D, Farah MG, Liner A, Fox K, Schluchter M, Hoit BD. The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance. J. Am. Soc. Echocardiogr.17(5), 443–447 (2004).
   PubMed Web of Science ®Google Scholar
• Bystrom B, Lindqvist P, Henein M. The right ventricle: knowing what is right. Int. J. Cardiovasc. Imaging24(7), 701–702 (2008).
   PubMed Web of Science ®Google Scholar
• Baur LH. Magnetic resonance imaging: the preferred imaging method for evaluation of the right ventricle. Int. J. Cardiovasc. Imaging24(7), 699–700 (2008).
   PubMed Web of Science ®Google Scholar
• Damiano RJ Jr, La Follette P Jr, Cox JL, Lowe JE, Santamore WP. Significant left ventricular contribution to right ventricular systolic function. Am. J. Physiol.261(5 Pt 2), H1514–H1524 (1991).
   PubMedGoogle Scholar
• Horowitz LN, Vetter VL, Harken AH, Josephson ME. Electrophysiologic characteristics of sustained ventricular tachycardia occurring after repair of Tetralogy of Fallot. Am. J. Cardiol.46(3), 446–452 (1980).
   PubMed Web of Science ®Google Scholar
• Downar E, Harris L, Kimber S et al. Ventricular tachycardia after surgical repair of Tetralogy of Fallot: results of intraoperative mapping studies. J. Am. Coll. Cardiol.20(3), 648–655 (1992).
   PubMed Web of Science ®Google Scholar
• Khairy P, Harris L, Landzberg MJ et al. Implantable cardioverter-defibrillators in Tetralogy of Fallot. Circulation117(3), 363–370 (2008).
   PubMed Web of Science ®Google Scholar
• Gatzoulis MA, Balaji S, Webber SA et al. Risk factors for arrhythmia and sudden cardiac death late after repair of Tetralogy of Fallot: a multicentre study. Lancet356(9234), 975–981 (2000).
   PubMed Web of Science ®Google Scholar
• Khairy P, Landzberg MJ, Gatzoulis MA et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation109(16), 1994–2000 (2004).
   PubMed Web of Science ®Google Scholar
• Zeltser I, Gaynor JW, Petko M et al. The roles of chronic pressure and volume overload states in induction of arrhythmias: an animal model of physiologic sequelae after repair of Tetralogy of Fallot. J. Thorac. Cardiovasc. Surg.130(6), 1542–1548 (2005).
   PubMed Web of Science ®Google Scholar
• Harrild DM, Berul CI, Cecchin F et al. Pulmonary valve replacement in Tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation119(3), 445–451 (2009).
   PubMed Web of Science ®Google Scholar
• Therrien J, Siu SC, Harris L et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of Tetralogy of Fallot. Circulation103(20), 2489–2494 (2001).
   PubMed Web of Science ®Google Scholar
• Khairy P HL, Landzberg MJ, Gatzoulis MA et al. Defibrillators in transposition of the great arteries with Mustard or Senning baffles. Heart Rhythm4, S95–S96 (2007).
   PubMed Web of Science ®Google Scholar
• Walsh EP. Interventional electrophysiology in patients with congenital heart disease. Circulation115(25), 3224–3234 (2007).
   PubMed Web of Science ®Google Scholar
• Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet373(9671), 1289–1300 (2009).
   PubMed Web of Science ®Google Scholar
• Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up. Int. J. Cardiol.107(3), 360–368 (2006).
   PubMed Web of Science ®Google Scholar
• Corrado D, Leoni L, Link MS et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation108(25), 3084–3091 (2003).
   PubMed Web of Science ®Google Scholar
• Wichter T, Paul M, Wollmann C et al. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation109(12), 1503–1508 (2004).
   PubMed Web of Science ®Google Scholar